Is GT Biopharma Inc (GTBP) a Good Buy in the Biotechnology Industry?

GT Biopharma Inc (GTBP) is near the middle in its industry group according to InvestorsObserver. GTBP gets an overall rating of 45. That means it scores higher than 45 percent of stocks. GT Biopharma Inc gets a 65 rank in the Biotechnology industry. Biotechnology is number 81 out of 148 industries.

GTBP has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on GTBP!

See Full GTBP Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 45 means the stock is more attractive than 45 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With GT Biopharma Inc Stock Today?

GT Biopharma Inc (GTBP) stock is trading at $7.24 as of 2:26 PM on Friday, Sep 24, a decline of -$0.19, or -2.56% from the previous closing price of $7.43. The stock has traded between $7.12 and $7.37 so far today. Volume today is light. So far 43,674 shares have traded compared to average volume of 397,552 shares. Click Here to get the full Stock Report for GT Biopharma Inc stock.